Literature DB >> 12474074

Structural implications of placing cationic residues at either the NH2- or COOH-terminus in a pore-forming synthetic peptide.

J R Broughman1, L P Shank, O Prakash, B D Schultz, T Iwamoto, J M Tomich, K Mitchell.   

Abstract

Restoration of chloride conductance via introduction of an anion-selective pore, formed by a channel-forming peptide, has been hypothesized as a novel treatment modality for patients with cystic fibrosis. Delivery of these peptides from an aqueous environment in the absence of organic solvents is paramount. M2GlyR peptides, designed based on the glycine receptor, insert into lipid bilayers and polarized epithelial cells and assemble spontaneously into chloride-conducting pores. Addition of 4 lysine residues to either terminus increases the solubility of M2GlyR peptides. Both orientations of the helix within the membrane form an anion-selective pore, however, differences in solubility, associations and channel-forming activity are observed. To determine how the positioning of the lysine residues affects these properties, structural characteristics of the lysyl-modified peptides were explored utilizing chemical cross-linking, NMR and molecular modeling. Initial model structures of the a-helical peptides predict that lysine residues at the COOH-terminus form a capping structure by folding back to form hydrogen bonds with backbone carbonyl groups and hydroxyl side chains of residues in the helical segment of the peptide. In contrast, lysine residues at the NH2-terminus form fewer H-bonds and extend away from the helical backbone. Results from NMR and chemical cross-linking support the model structures. The C-cap formed by H-bonding of lysine residues is likely to account for the different biophysical properties observed between NH2- and COOH-terminal-modified M2GlyR peptides.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12474074     DOI: 10.1007/s00232-002-1027-3

Source DB:  PubMed          Journal:  J Membr Biol        ISSN: 0022-2631            Impact factor:   1.843


  8 in total

1.  Redesigning channel-forming peptides: amino acid substitutions that enhance rates of supramolecular self-assembly and raise ion transport activity.

Authors:  Lalida P Shank; James R Broughman; Wade Takeguchi; Gabriel Cook; Ashley S Robbins; Lindsey Hahn; Gary Radke; Takeo Iwamoto; Bruce D Schultz; John M Tomich
Journal:  Biophys J       Date:  2005-12-30       Impact factor: 4.033

2.  Immunity to a self-derived, channel-forming peptide in the respiratory tract.

Authors:  Frederik W van Ginkel; Takeo Iwamoto; Bruce D Schultz; John M Tomich
Journal:  Clin Vaccine Immunol       Date:  2007-12-19

3.  Effect of diaminopropionic acid (Dap) on the biophysical properties of a modified synthetic channel-forming peptide.

Authors:  Urska Bukovnik; Monica Sala-Rabanal; Simonne Francis; Shawnalea J Frazier; Bruce D Schultz; Colin G Nichols; John M Tomich
Journal:  Mol Pharm       Date:  2013-09-23       Impact factor: 4.939

4.  Epithelial barrier modulation by a channel forming peptide.

Authors:  Suma Somasekharan; Robert Brandt; Takeo Iwamoto; John M Tomich; Bruce D Schultz
Journal:  J Membr Biol       Date:  2008-03       Impact factor: 1.843

Review 5.  The 5-HT3 receptor as a therapeutic target.

Authors:  Andrew J Thompson; Sarah C R Lummis
Journal:  Expert Opin Ther Targets       Date:  2007-04       Impact factor: 6.902

6.  Structural characterization of two pore-forming peptides: consequences of introducing a C-terminal tryptophan.

Authors:  Alvaro I Herrera; Ahlam Al-Rawi; Gabriel A Cook; Jian Gao; Takeo Iwamoto; Om Prakash; John M Tomich; Jianhan Chen
Journal:  Proteins       Date:  2010-08-01

Review 7.  Transmembrane helix dimerization: beyond the search for sequence motifs.

Authors:  Edwin Li; William C Wimley; Kalina Hristova
Journal:  Biochim Biophys Acta       Date:  2011-09-01

8.  Activity and structural comparisons of solution associating and monomeric channel-forming peptides derived from the glycine receptor m2 segment.

Authors:  Gabriel A Cook; Om Prakash; Ke Zhang; Lalida P Shank; Wade A Takeguchi; Ashley Robbins; Yu-Xi Gong; Takeo Iwamoto; Bruce D Schultz; John M Tomich
Journal:  Biophys J       Date:  2004-03       Impact factor: 4.033

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.